1. China Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Chengzhi Co. Ltd. Class A

Chengzhi Co. Ltd. Class A

SSZSE:000990
5.40
CNY
-0.22
(-3.91%)
9.94BMarket Cap
Apr 21Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9.64
8.96
7.54
4.75
3.25
3.35
4.05
5.72
7.16
6.89
7.3
6.5
6.48
- -
Basic EPS, GAAP
0.12
0.16
0.26
0.2
0.46
0.48
0.26
0.21
0.59
0.03
0.1
0.14
-0.05
- -
Free Cash Flow per Basic Share
0.23
-0.45
-0.5
-0.31
0.65
-0.3
-0.06
0.57
0.75
0.56
0.29
0.11
0.15
- -
Dividend per Share
0.14
0.2
0.14
0.19
0.18
0.22
0.37
0.18
0.13
0.12
0.17
0.13
0.13
0.07
Book Value per Share
3.97
4.27
5.27
8.71
9.07
9.22
9.2
9.4
10.06
10.48
10.37
10.48
10.4
10.59
Tangible Book Value per Share
2.98
3.56
4.36
4.32
4.72
4.95
4.79
5.03
5.91
6.13
6.07
5.93
5.88
6.09
Basic Weighted Avg Shares
415
448
536
542
1,754
1,754
1,707
1,701
1,701
1,702
1,701
1,702
1,701
1,701
Sales/Revenue/Turnover
4,000
4,011
4,042
2,574
5,695
5,868
6,912
9,732
12,184
11,717
12,417
11,066
11,028
- -
Operating Margin (%)
3.11
2.3
2.26
10.94
18.69
18.78
12.95
9.6
14.64
3.7
6.57
7.61
4.22
- -
Depreciation Expense
73
85
124
144
452
448
494
621
621
594
661
657
663
- -
Net Income, GAAP
52
73
138
111
809
849
443
355
1,008
51
177
231
-78
- -
Effective Tax Rate (%)
32.39
9.85
19.85
21.04
15.98
13.85
12.75
21.62
18.4
6.23
20.22
24.54
5.41
- -
Profit Margin (%)
1.3
1.83
3.41
4.3
14.2
14.47
6.4
3.65
8.28
0.43
1.43
2.08
-0.71
- -
Working Capital
485
634
730
2,418
3,451
1,031
704
544
1,963
1,150
916
1,224
1,924
2,889
LT Debt
350
50
194
522
1,279
2,253
2,603
1,929
1,540
598
1,129
2,192
3,793
4,113
Total Equity
1,694
2,342
3,050
15,519
16,066
16,325
16,345
16,697
18,463
18,677
18,463
18,733
18,677
19,095
Return on Invested Capital (%)
1.73
-0.04
2.12
1.07
3.55
4
2.17
1.71
4.99
0.77
1.38
1.43
0.51
- -
Return on Capital (%)
3.68
4.24
4.26
1.15
4.97
5.07
3.28
2.74
5.18
0.58
0.88
1.03
-0.37
- -
Return on Common Equity (%)
3.18
3.69
5.33
1.22
5.19
5.29
2.74
2.18
5.91
0.29
1
1.3
-0.44
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2,631
1,990
1,960
LT Borrowings
3,399
4,225
3,748
LT Finance Leases
393
377
365
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,701
1,701
1,701
Market Capitalization
9,625
11,909
9,941

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
6,583
6,978
6,649
Cash, Cash Equivalents & STI
3,521
3,783
3,511
Accounts Receivable, Net
1,014
1,273
1,124
Inventories
1,027
1,057
1,104
Total Current Liabilities
4,658
3,909
3,760
Payables & Accruals
- -
- -
- -
ST Debt
2,631
1,990
1,960
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
42.8%
2.35%
-0.3%
Free Cash Flow
-218.16%
-12.97%
40.1%
Net Income, GAAP
78.11%
46.7%
-133.89%
Sales/Revenue/Turnover
16.27%
3.22%
-0.35%
Total Cash Common Dividend
26.52%
-3.49%
-2.39%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,721
2,940
2,577
2,829
11,066
2025
2,998
2,983
- -
2,324
11,028
2026
2,836
3,311
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.02
0.02
0.01
0.14
2025
0.05
-0.04
- -
-0.11
-0.05
2026
0.14
0.03
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.06
0.02
0.02
0.13
2025
0.02
0.06
- -
0.02
0.13
2026
0.02
0.03
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Junmin Wei
Full Time Employees
4,462
Sector
Process industries
Industry
Chemicals: specialty
Address
Huajiang Building Nanchang JX China 330013
IPO Date
Jul 6, 2000
Website
chengzhi.com.cn
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
Dow Inc. (NYSE:DOW)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Business
Chengzhi Shareholding Co., Ltd. Chengzhi Co., Ltd. (000990.SZ) is a state-owned Chinese high-tech conglomerate primarily engaged in clean energy, semiconductor display materials, medical healthcare, and life science businesses. The company produces and sells a wide range of gas products including carbon monoxide, syngas, butadiene, isobutanal, ethane, propane, crude benzene, ethylene, hydrogen, propylene, butanoctyl, diolefin and other chemicals; life science and technology products such as D-ribose and industrial hemp; functional materials for new displays encompassing industrial control displays, on-board displays, IT displays, liquid crystal materials, OLED materials and other specialty chemicals; as well as daily and special chemicals, edible fats and oils, paper products, sanitary and household paper products, auto parts, machinery, electronics and biological pharmaceuticals. It also provides hospital management services to general hospitals, health clinics and specialized medical providers, alongside consulting, property management and hospital investment management. Founded in 1998 and headquartered in Nanchang, China, with management headquarters in Beijing, the company operates primarily within China across these diversified segments targeting industrial, healthcare and technology markets. Recent developments include the acquisition of a 15% stake in its Anhui-based display glass subsidiary for 90.5 million yuan to bolster semiconductor materials capabilities, and its wholly-owned hospital investment subsidiary establishing a joint venture for health industry investments with a 2.4 million yuan contribution, reflecting strategic expansions in display technology and healthcare sectors within the last few years.